Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

ClinicalTrials.gov ID: NCT04849988

Public ClinicalTrials.gov record NCT04849988. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study to Evaluate the Safety and Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 2 trial will evaluate the safety and efficacy of ABP-450 for the treatment of cervical dystonia in adults. The study will enroll 60 patients across approximately 30 sites in the United States. Study subjects will be divided evenly across a low dose group, a medium dose group, a high dose group, and a placebo group for one treatment cycle.

Study identification

NCT ID
NCT04849988
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AEON Biopharma, Inc.
Industry
Enrollment
61 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2021 (Actual)
Primary completion
Jul 11, 2022 (Actual)
Completion
Jul 11, 2022 (Actual)
Last update posted
Feb 14, 2024

2021 – 2022

United States locations

U.S. sites
21
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Arizona Neuroscience Research Phoenix Arizona 85032 —
Movement Disorder Center of Arizona Scottsdale Arizona 85258 —
Parkinson's and Movement Disorder Institute Fountain Valley California 92708 —
Neuro Pain Medical Center Fresno California 93710 —
Loma Linda University Loma Linda California 92354 —
New England Institute for Neurology and Headache Stamford Connecticut 06905 —
Infinity Clinical Research LLC Hollywood Florida 33024 —
The Neurology Research Group Miami Florida 33176 —
University of South Florida Tampa Florida 33613 —
Neurology One Winter Park Florida 32792 —
Emory University Atlanta Georgia 30329 —
Rush University Medical Center Chicago Illinois 60612 —
Michigan State University East Lansing Michigan 48824 —
Quest Research Institute - Hunt - PPDS Farmington Hills Michigan 48334 —
University of New Mexico Albuquerque New Mexico 87106 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Cleveland Clinic Lou Ruvo Center for Brain Health Cleveland Ohio 89106 —
The Orthopedic Foundation New Albany Ohio 43054 —
Veracity Neuroscience LLC Memphis Tennessee 38157 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Baylor College of Medicine Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04849988, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 14, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04849988 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →